Raymond James upgraded shares of Invesco S&P Emerging Markets Low Volatility Index ETF (TSE:ELV – Free Report) to a strong-buy rating in a research report sent to investors on Wednesday morning,Zacks.com reports.
Separately, Alliance Global Partners upgraded shares of Invesco S&P Emerging Markets Low Volatility Index ETF to a “strong-buy” rating in a research report on Thursday, September 26th.
Get Our Latest Research Report on ELV
Invesco S&P Emerging Markets Low Volatility Index ETF Stock Performance
About Invesco S&P Emerging Markets Low Volatility Index ETF
Elevance Health Inc operates as a health benefits company. It supports consumers, families, and communities across the entire care journey connecting to the care, support, and resources to lead healthier lives. It serves approximately 118 million people through a portfolio of medical, digital, pharmacy, behavioral, clinical, and care solutions.
Featured Stories
- Five stocks we like better than Invesco S&P Emerging Markets Low Volatility Index ETF
- Short Selling: How to Short a Stock
- Abbott Laboratories Will Outperform Healthcare Stocks in 2025
- Dividend Capture Strategy: What You Need to Know
- PepsiCo: 53 Years of Dividend Growth and Still Going Strong
- ETF Screener: Uses and Step-by-Step Guide
- Cash Flow Focus: Thermo Fisher, Energy Transfer, and NetEase
Receive News & Ratings for Invesco S&P Emerging Markets Low Volatility Index ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Invesco S&P Emerging Markets Low Volatility Index ETF and related companies with MarketBeat.com's FREE daily email newsletter.
